India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.

Asian shares were trading mixed Wednesday as markets mulled the impact of tariffs being imposed by the United States and China. Japan's benchmark Nikkei 225 recouped earlier losses and was little ...

BRP Inc. (TSX:DOO) faces a U.S. tariff storm—70% of its production is in Mexico, some in Canada, yet 60% of sales depend on ...

Much has happened during China's week-long Lunar New Year holiday. Over the weekend, Trump imposed levies on goods from China, a move that prompted Beijing to announce targeted tariffs on U.S. imports ...

Calm returned to Wall Street Tuesday, and tech stocks led U.S. indexes higher following a strong profit report from Palantir ...

Calm returned to Wall Street, and tech stocks led U.S. indexes higher after a strong profit report from Palantir Technologies ...

The number of job openings in December fell to 7.6 million, according to JOLTS data. That's down from 8.2 million in November and close to it's four-year low. Hires and separations were little changed ...

Beijing hit back with its own tariffs and export restrictions after being subjected to levies by President Trump. Trade ...

Analyzing PepsiCo, Inc.'s stock drop, financial health, and growth strategies, highlighting a buying opportunity for ...

President Donald Trump has taken executive action to impose or threaten new tariffs on imports from Canada, Mexico and China.

It was chaos.” That's how Renaldo Agostino would describe the last 24 hours in Windsor, hours ahead of a trade war deadline between Canada and the United States.